What is the equity of Bristol-Myers Squibb this year?
Bristol-Myers Squibb has equity of 29.43 B USD this year.
Bristol-Myers Squibb Equity 2024
Bristol-Myers Squibb Equity
29.43 B USD
Ticker
BMY
ISIN
US1101221083
WKN
850501
In 2024, Bristol-Myers Squibb's equity was 29.43 B USD, a -5.25% increase from the 31.06 B USD equity in the previous year.
Bristol-Myers Squibb Aktienanalyse
What does Bristol-Myers Squibb do?
Bristol-Myers Squibb Co is a global biopharmaceutical company focused on the research, development, and production of prescription drugs and biosimilars for the treatment of serious diseases. The company is headquartered in New York, USA, and employs approximately 30,000 people worldwide. Bristol-Myers Squibb ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Bristol-Myers Squibb's Equity
Bristol-Myers Squibb's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Bristol-Myers Squibb's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Bristol-Myers Squibb's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Bristol-Myers Squibb's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Bristol-Myers Squibb’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Bristol-Myers Squibb Stock
What was the equity of Bristol-Myers Squibb compared to the previous year?
The equity of Bristol-Myers Squibb has increased/decreased by -5.25% decreased compared to the previous year.
What impact does a high equity have on investors of Bristol-Myers Squibb?
A high equity is advantageous for investors of Bristol-Myers Squibb as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Bristol-Myers Squibb?
A low equity can be a risk for investors of Bristol-Myers Squibb, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Bristol-Myers Squibb affect the company?
An increase in equity of Bristol-Myers Squibb can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Bristol-Myers Squibb affect the company?
A reduction in equity of Bristol-Myers Squibb can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Bristol-Myers Squibb?
Some factors that can affect the equity of Bristol-Myers Squibb include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Bristol-Myers Squibb so important for investors?
The equity of Bristol-Myers Squibb is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Bristol-Myers Squibb take to change the equity?
To change equity, Bristol-Myers Squibb can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Bristol-Myers Squibb pay?
Over the past 12 months, Bristol-Myers Squibb paid a dividend of 2.28 USD . This corresponds to a dividend yield of about 5.53 %. For the coming 12 months, Bristol-Myers Squibb is expected to pay a dividend of 2.43 USD.
What is the dividend yield of Bristol-Myers Squibb?
The current dividend yield of Bristol-Myers Squibb is 5.53 %.
When does Bristol-Myers Squibb pay dividends?
Bristol-Myers Squibb pays a quarterly dividend. This is distributed in the months of August, November, February, May.
How secure is the dividend of Bristol-Myers Squibb?
Bristol-Myers Squibb paid dividends every year for the past 26 years.
What is the dividend of Bristol-Myers Squibb?
For the upcoming 12 months, dividends amounting to 2.43 USD are expected. This corresponds to a dividend yield of 5.9 %.
In which sector is Bristol-Myers Squibb located?
Bristol-Myers Squibb is assigned to the 'Health' sector.
Wann musste ich die Aktien von Bristol-Myers Squibb kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Bristol-Myers Squibb from 5/1/2024 amounting to 0.6 USD, you needed to have the stock in your portfolio before the ex-date on 4/4/2024.
When did Bristol-Myers Squibb pay the last dividend?
The last dividend was paid out on 5/1/2024.
What was the dividend of Bristol-Myers Squibb in the year 2023?
In the year 2023, Bristol-Myers Squibb distributed 2.16 USD as dividends.
In which currency does Bristol-Myers Squibb pay out the dividend?
The dividends of Bristol-Myers Squibb are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Bristol-Myers Squibb stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von Bristol-Myers Squibb
Our stock analysis for Bristol-Myers Squibb Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bristol-Myers Squibb Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Bristol-Myers Squibb Revenue
- Bristol-Myers Squibb Net Income
- Bristol-Myers Squibb P/E
- Bristol-Myers Squibb P/S
- Bristol-Myers Squibb EBIT
- Bristol-Myers Squibb Dividend
- Bristol-Myers Squibb Stocks
- Bristol-Myers Squibb Market capitalization
- Bristol-Myers Squibb Debt
- Bristol-Myers Squibb Liabilities
- Bristol-Myers Squibb Equity
- Bristol-Myers Squibb AAQS
- Bristol-Myers Squibb Employees
- Bristol-Myers Squibb ROE
- Bristol-Myers Squibb ROA
- Bristol-Myers Squibb ROCE
